YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs.
JTO Clin Res Rep
; 3(2): 100278, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-35199053
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
JTO Clin Res Rep
Year:
2022
Type:
Article
Affiliation country:
Italy